Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial

ABSTRACT To the best of our knowledge, this is one of very few reports on long-term survival after trimodality therapy for locally advanced stage IIIB NSCLC. It demonstrates that selected patients can be cured by such an intensive treatment. Extended follow-up beyond 5 years, including chest imaging and optimal control of cardiovascular risk factors should be integrated in future clinical trials.